BRITISH SOCIETY FOR ANTIMICROBIAL CHEMOTHERAPY
Financial health, per its FY2025 accounts
The accounts state that free reserves totalled £10,798,990, which exceeds the Trustees' policy target of maintaining reserves sufficient to cover at least 24 months' expenditure. The charity reported a net income of £864,434 for the year, supported by strong investment gains of £521,312, and the Trustees confirmed there is no material uncertainty regarding its ability to continue as a going concern.
What the accounts disclose
“In the band £110,001 -120,000 1”
“10 Trustees of the charitable company received £13,533 (2024 £16,468) in relation to reimbursed expenses for travel and subsistence incurred as part of their role as trustees.” — page 39
“In total, the charitable company paid £3,103 (2024 £5,498) to third parties for travel and subsistence of trustees for expenses incurred as part of their role as Trustee and for speaking at conferences, events and otherwise representing BSAC.”
“10 Trustees of the charitable company received £13,533 (2024 £16,468) in relation to reimbursed expenses for travel and subsistence incurred as part of their role as trustees.” — page 39
“In total, the charitable company paid £3,103 (2024 £5,498) to third parties for travel and subsistence of trustees for expenses incurred as part of their role as Trustee and for speaking at conferences, events and otherwise representing BSAC.”
Year-over-year changes
- Top pay band moved from £80,001 - £90,000 (FY2024) to £110,001 - £120,000 (FY2025).
Structured financials (annual return, FY ending 30/09/2025)
Trustees
- Dr Alicia Demirjian
- Dr Amelia Joseph
- Dr Andrew Seaton
- Dr Aoife Fleming
- Dr Christopher Longshaw
- Dr Elizabeth Tayler
- Dr Helena Parsons
- Dr Ioannis Baltas
- Dr Jane Democratis
- Dr Kenneth Egwu
- Dr Louise Sweeney
- Dr MATTHEW DRYDEN
- Dr Michael Allen
- Dr Miruna David
- Dr Rasha Elsenawy
- Professor Michelle Buckner
- Professor Paul Long
- Sally Tipping
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 30/09/2025 | £2.7m | £2.3m |
| 30/09/2024 | £2.6m | £2.4m |
| 30/09/2023 | £2.7m | £2.6m |
| 30/09/2022 | £2.8m | £2.7m |
| 30/09/2021 | £2.6m | £2.1m |
Common questions
Is BRITISH SOCIETY FOR ANTIMICROBIAL CHEMOTHERAPY financially healthy?
The accounts state that free reserves totalled £10,798,990, which exceeds the Trustees' policy target of maintaining reserves sufficient to cover at least 24 months' expenditure. The charity reported a net income of £864,434 for the year, supported by strong investment gains of £521,312, and the Trustees confirmed there is no material uncertainty regarding its ability to continue as a going concern. Its FY2025 accounts were audited by MHA.
What does the highest-paid employee of BRITISH SOCIETY FOR ANTIMICROBIAL CHEMOTHERAPY earn?
Per its FY2025 accounts, the highest-paid employee was in the £110,001 - £120,000 band.
Funders of similar charities
| Funder | Similar charities funded | Amount to them |
|---|---|---|
| THE COMPANY OF BIOLOGISTS | 2 | £178k |